# CMR Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cmr-surgical

- Industry: Medical Devices & Equipment
- Headquarters: Cambridge, UK
- Website: www.cmrsurgical.com
- Total disclosed funding: $1.5B
- Investors on record: 13

## About

Based in Cambridge, UK, and founded in 2014, CMR Surgical Limited is a global surgical robotics business that develops Versius, a surgical robotic tool for healthcare providers. The company was co-founded by Luke Hares, Mark Slack, and Martin Frost. The company has launched operations across Europe, Australia, India, and the Middle East. In June 2021, CMR Surgical Limited received USD 600 million in Series D funding from SoftBank Vision Fund 2 and Ally Bridge Group. In April 2025, CMR Surgical Limited raised approximately USD 200 million in equity and debt funding from Trinity Capital and other unspecified investors. The company works with surgeons and hospitals and offers a robotic surgical tool with value-based medicine and 3D high-definition imagery that works in operation. CMR Surgical’s Versius uses V-wrist technology that helps surgeons and the surgical teams to deliver MAS (Minimum Access Surgeries) with precision and control. Versius provides surgical teams with access, team communication, training, and support. The company plans to use the September 2023 funding to develop robotic-aided minimal access surgery, including new technological developments, and to support the further commercialisation of the system in existing and new geographies.

## Funding rounds

- Round, Oct 16, 2026, $397M
- Series D, Jul 1, 2021, $652M — Railways Pension Scheme, GE Healthcare, Lightrock, Ally Bridge Group, Cambridge Innovation Capital, Tencent Holdings Limited, SB Investment Advisers, Watrium, Chimera Partners Limited, PFM Health Sciences
- Series C, Sep 11, 2019, $263M — GE Healthcare, Lightrock, Cambridge Innovation Capital, Silk Road Fund, Escala Capital, Watrium
- Series B, Apr 23, 2018, $104M — Lightrock, Cambridge Innovation Capital, Silk Road Fund, Escala Capital, Watrium
- Series A, Aug 10, 2017, $26M — ABB Technology Ventures, Lightrock, Cambridge Innovation Capital, Escala Capital, Watrium
- Series A, Jul 13, 2016, $20M — ABB Technology Ventures, Lightrock, Cambridge Innovation Capital
- Seed, Jan 28, 2014 — Escala Capital

## Investors

- Escala Capital (https://capitalatlas.ai/funds/escala-capital) — Seed, Series A, Series B, Series C
- ABB Technology Ventures (https://capitalatlas.ai/funds/abb-technology-ventures) — Series A
- Lightrock (https://capitalatlas.ai/funds/lightrock) — Series A, Series B, Series C, Series D
- Cambridge Innovation Capital (https://capitalatlas.ai/funds/cambridge-innovation-capital) — Series A, Series B, Series C, Series D
- Watrium — Series A, Series B, Series C, Series D
- Silk Road Fund (https://capitalatlas.ai/funds/silk-road-fund) — Series B, Series C
- GE Healthcare — Series C, Series D
- Railways Pension Scheme — Series D
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series D
- Tencent Holdings Limited — Series D
- SB Investment Advisers (https://capitalatlas.ai/funds/sb-investment-advisers) — Series D
- Chimera Partners Limited — Series D
- PFM Health Sciences (https://capitalatlas.ai/funds/pfm-health-sciences) — Series D